|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 747906-747915 of 2349007 (234901 Page(s) Totally)
<< < 74786 74787 74788 74789 74790 74791 74792 74793 74794 74795 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2015 |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Thaci, Diamant; Blauvelt, Andrew; Reich, Kristian; Tsai, Tsen-Fang; Vanaclocha, Francisco; Kingo, Kuelli; Ziv, Michael; Pinter, Andreas; Hugot, Sophie; You, Ruquan; Milutinovic, Marina; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T18:07:35Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study
|
Blauvelt, A. And Reich, K. And Tsai, T.-F. And Tyring, S. And Vanaclocha, F. And Kingo, K. And Ziv, M. And Pinter, A. And Vender, R. And Hugot, S. And You, R. And Milutinovic, M. And Tha?I, D.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:53Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study
|
Blauvelt A.; Reich K.; TSEN-FANG TSAI; Tyring S.; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Hugot S.; You R.; Milutinovic M.; Tha?i D. |
| 臺大學術典藏 |
2019-02-13T05:40:17Z |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
|
TSEN-FANG TSAI; TSEN-FANG TSAI |
| 國立臺灣大學 |
2016 |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
van de Kerkhof, Peter C. M.; Griffiths, Christopher E. M.; Reich, Kristian; Leonardi, Craig L.; Blauvelt, Andrew; Tsai, Tsen-Fang; Gong, Yankun; Huang, Jiaqing; Papavassilis, Charis; Fox, Todd; 蔡呈芳 |
| 臺大學術典藏 |
2018-09-10T15:39:05Z |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
Van De Kerkhof, P.C.M. and Griffiths, C.E.M. and Reich, K. and Leonardi, C.L. and Blauvelt, A. and Tsai, T.-F. and Gong, Y. and Huang, J. and Papavassilis, C. and Fox, T.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:55Z |
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
|
Fox T.; Papavassilis C.; Huang J.; Gong Y.; TSEN-FANG TSAI; Blauvelt A.; Leonardi C.L.; Griffiths C.E.M.; Reich K.; Van De Kerkhof P.C.M. |
| 國立臺灣大學 |
2015 |
Secukinumab treatment shows no evidence for reactivation of previous or latent TB infection in subjects with psoriasis: A pooled phase 3 safety analysis
|
Tsai, Tsen-Fang; Blauvelt, Andrew; Gong, Yankun; Huang, Jiaqing; Fox, Todd; 蔡呈芳 |
| 國立臺灣師範大學 |
2016-03-22T06:50:46Z |
Secular Change of Diurnal Temperature Range in Taiwan (1901~2008)
|
翁叔平; 黃燕儀 |
| 國立臺灣大學 |
1993 |
Secular Changes in the Clinical Manifestation and Pathologic Pattern of Early Gastric Cancer in Taiwan
|
林肇堂; 吳明賢; 王錦堂; 陳楷模; 魏達成; 孫家棟; 陳建仁; 王秀伯; 陳子文; 王德宏; LIN, JAW-TOWN; WU, MING-SHIANG; WANG, JIN-TOWN; CHEN, KAI-MO; WEI, TA-CHENG; SHUN, CHIA-TUNG; CHEN, CHIEN-JEN; WANG, HSIU-PO; CHAN, TZE-MAN; WANG, TEH-HONG |
Showing items 747906-747915 of 2349007 (234901 Page(s) Totally)
<< < 74786 74787 74788 74789 74790 74791 74792 74793 74794 74795 > >>
View [10|25|50] records per page
|
